Spotlight On... Sun closing Ranbaxy plant in Ireland; U.K. finds fault with Alkem plant; Serbia seeks investment in Galenika; and more...

sun pharma building

Sun Pharmaceutical will lay off about 70 workers and close a plant in Ireland as it cuts back its manufacturing network following its buyout of Ranbaxy Laboratories last year. Sun had put the plant up for sale last year but was unable to find a buyer. According to the Irish Times, a company statement said the plant would close by the end of the year but the company intends to move some jobs to other facilities in its network. "The Cashel facility closure is being implemented as part of this plan to right size the company's global manufacturing activities," said a statement sent to the newspaper. "We expect to cease operations at Cashel by end of current calendar year." Story | More

> Indian drugmaker Alkem Laboratories says the U.K.'s inspectors noted 8 observations during an inspection of a plant in Taloja, Maharashtra. Report

> Indian drugmaker Makers Pharma says it will sell a plant in Thane. Report

> Serbia is inviting bids for a 25% share in its debt-laden and money-losing pharma company, Galenika. Story